Reaching consensus on Covid-19 vax patent waiver may take time: Experts

Developed nations opposed the proposal, though it received the support of three-fourths of member nations

As India revises its proposal calling for a temporary patent waiver on Covid-19 vaccines to expedite the discussion at the World Trade Organization (WTO), the path to reaching a consensus could be a long-drawn-out affair, experts said.
 
Experts said that even after consensus is reached among the member countries on waiving sections of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement and the proposal becomes law, implementation will be the key to addressing the shortage vaccines in many countries.
 
RV Anuradha, partner at Clarus Law Associates, said diplomatic negotiations are moving at a slow pace, not keeping